Rupesh Rajesh Kotecha, MD

Noah Kalman, M.D., MBA, is a radiation oncologist specializing in the treatment of gynecologic, head and neck, thoracic and pediatric cancers, melanoma and non-melanoma skin cancers and sarcoma. He has special training and expertise in advanced radiation therapies such as stereotactic body radiation therapy, linear accelerator-based stereotactic radiosurgery and proton therapy. Dr. Kalman is actively involved in clinical research to improve treatment efficacy and patient outcomes. He has been recognized for his academic and clinical excellence. He serves as an editorial reviewer for several peer-reviewed scientific journals. He also is widely published in numerous medical journals and lectures at scientific symposiums.

Matthew Hall, M.D., is the lead pediatric radiation oncologist at Miami Cancer Institute, a part of Baptist Health South Florida. He is Board certified in radiation oncology and has extensive training and experience in standard photon therapy and proton therapy – a highly advanced form of radiation technology that targets cancer cells with pencil-beam scanning precision while sparing the surrounding healthy tissue. His clinical specialty and research focus on innovative ways to treat cancer with radiation therapy while minimizing long-term side effects. He has authored more than a dozen scientific articles in his specialty and has presented posters and abstracts at numerous national and international meetings. Dr. Hall is a member the American Society for Radiation Oncology, the American College of Radiation and several other scientific and medical societies. He received his medical degree from the University of Illinois College of Medicine in Peoria, graduating with honors. He also earned a master’s degree in business administration from the University of Illinois Liautaud Graduate School of Business in Chicago. He served as chief resident during his radiation oncology residency at City of Hope National Medical Center in Duarte. He continued his postdoctoral training at the University of Florida Health Proton Therapy Institute in Jacksonville, completing a fellowship in adult radiation oncology and a fellowship in pediatric radiation oncology. During his schooling, Dr. Hall was inducted into such prestigious honor societies as Phi Beta Kappa and Alpha Omega Alpha Honor Medical Society.

Adeel Kaiser, M.D., is a board-certified radiation oncologist at Baptist Health Miami Cancer Institute and clinical associate professor at Florida International University Herbert Wertheim College of Medicine. He specializes in the treatment of gastrointestinal and genitourinary cancers using proton beam, IMRT, and theranostic and MRI-guided adaptive therapies. He aims to provide each patient with a personalized, integrative treatment strategy for their cancer by incorporating complementary therapies with state-of-the-art radiation technology. Dr. Kaiser attained his undergraduate and medical degrees from Johns Hopkins University and completed his radiation oncology training at the University of California Irvine/City of Hope Integrated Program in Radiation Oncology. Prior to joining Miami Cancer Institute, he held faculty appointments at the University of Maryland, Johns Hopkins University and Loma Linda University. At the University of Maryland, he served as director of the Advanced Modalities Fellowship Program. This program trained national and international students in emerging radiation oncology modalities, including pencil beam proton therapy, GammaPod radiosurgery and deep tissue hyperthermia. Dr. Kaiser also served as instructor of the Varian Proton Therapy School as well as director of the Integrative Wellness Program at the Maryland Proton Treatment Center, which sought to incorporate diet, exercise, acupuncture and emotional support strategies with radiation therapy. Dr. Kaiser is widely published in peer-reviewed medical journals. He has led multiple clinical trials and was the first radiation oncologist to lead an NIH-funded ketogenic diet pilot study for patients undergoing active surveillance for prostate cancer. Dr. Kaiser is fluent in English, Urdu and Hindi.